The significance of pathological spontaneous activity in various myopathies

Clinical Neurophysiology

Volumn 125, Issue 7, 2014, Pages 1485-1490

  Hanisch, F ^a   Kronenberger, C ^a   Zierz, S ^a   Kornhuber, M ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Complex repetitive discharges; Electromyography; Limb girdle muscular dystrophy; Matrin 3 myopathy; Myotonic discharges

Indexed keywords

ADULT; AGED; ALPHA DYSTROGLYCAN DEFICIENCY; ARTICLE; BECKER MUSCULAR DYSTROPHY; CALPAINOPATHY; CENTRONUCLEAR MYOPATHY; DISTAL MYOPATHY; DYSFERLINOPATHY; ELECTROMYOGRAPHY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE MUTATION; GLYCOGEN STORAGE DISEASE TYPE 2; HIGH FREQUENCY DISCHARGE; HUMAN; LIMB GIRDLE MUSCULAR DYSTROPHY; MAJOR CLINICAL STUDY; MATRIN 3 MYOPATHY; MIYOSHI MYOPATHY; MUSCULOSKELETAL SYSTEM PARAMETERS; MYOPATHY; MYOTONIA; MYOTONIC DYSTROPHY; NEEDLE ELECTRODE; PARASPINAL MUSCLE; PATHOLOGICAL SPONTANEOUS ACTIVITY; POSITIVE SHARP WAVES DISCHARGE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCREENING; FEMALE; GLYCOGEN STORAGE DISEASE TYPE II; MALE; MIDDLE AGED; MUSCULAR DISEASES; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; PATHOPHYSIOLOGY;

ADULT; ELECTROMYOGRAPHY; FEMALE; GLYCOGEN STORAGE DISEASE TYPE II; HUMANS; MALE; MIDDLE AGED; MUSCULAR DISEASES; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; RETROSPECTIVE STUDIES;

EID: 84901276324     PISSN: 13882457     EISSN: 18728952     Source Type: Journal    
DOI: 10.1016/j.clinph.2013.11.021     Document Type: Article

References (46)

1. American Association of Electrodiagnostic Medicine glossary of terms in electrodiagnostic medicine. Muscle Nerve 2001; Suppl 10: S1-S50.
2. American Association of Neuromuscular & Electrodiagnostic Medicine Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle Nerve 2009, 40:149-160.
3. Blijham P.J., Hengstman G.J., Hama-Amin A.D., van Engelen B.G., Zwarts M.J. Needle electromyographic findings in 98 patients with myositis. Eur Neurol 2006, 55:183-188.
4. Bolduc V., Marlow G., Boycott K.M., Saleki K., Inoue H., Kroon J., et al. Recessive mutations in the putative calcium-activated chloride channel Anoctamin 5 cause proximal LGMD2L and distal MMD3 muscular dystrophies. Am J Hum Genet 2010, 86:213-221.
5. Bourteel H., Vermersch P., Cuisset J.M., Maurage C.A., Laforet P., et al. Clinical and mutational spectrum of limb-girdle muscular dystrophy type 2I in 11 French patients. J Neurol Neurosurg Psychiatry 2009, 80:1405-1408.
6. Butz M., Koch M.C., Müller-Felber W., Lemmers R.J., van der Maarel S.M., et al. Facioscapulohumeral muscular dystrophy. Phenotype-genotype correlation in patients with borderline D4Z4 repeat numbers. J Neurol 2003, 250:932-937.
7. Dabby R., Lange D.J., Trojaborg W., Hays A.P., Lovelace R.E., et al. Inclusion body myositis mimicking motor neuron disease. Arch Neurol 2001, 58:1253-1256.
8. Day J.W., Ricker K., Jacobsen J.F., Rasmussen L.J., Dick K.A., Kress W., et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003, 60:657-664.
9. Deschauer M., Joshi P.R., Gläser D., Hanisch F., Stoltenburg G., Zierz S. Muscular dystrophy due to mutations in anoctamin 5: clinical and molecular genetic findings. Nervenarzt 2011, 82:1596-1603.
10. Echaniz-Laguna A., Nicot A.S., Carré S., Franques J., Tranchant C., Dondaine N., et al. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation. Neuromuscul Disord 2007, 17:955-959.
11. Emeryk-Szajewska B., Kopeć J. Electromyographic pattern in Duchenne and Becker muscular dystrophy. Part I: Electromyographic pattern in subsequent stages of muscle lesion in Duchenne muscular dystrophy. Electromyogr Clin Neurophysiol 2008, 48:265-277.
12. Emeryk-Szajewska B., Kopeć J. Electromyographic pattern in Duchenne and Becker muscular dystrophy. Part II. Electromyographic pattern in Becker muscular dystrophy in comparison with Duchenne muscular dystrophy. Electromyogr Clin Neurophysiol 2008, 48:279-284.
13. Felice K.J., Moore S.A. Unusual clinical presentations in patients harboring the facioscapulohumeral dystrophy 4q35 deletion. Muscle Nerve 2001, 24:352-356.
14. Felice K.J., North W.A. Inclusion body myositis in Connecticut: observations in 35 patients during an 8-year period. Medicine (Baltimore) 2001, 80:320-327.
15. Feit H., Silbergleit A., Schneider L.B., Gutierrez J.A., Fitoussi R.P., Réyès C., et al. Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: clinical description and gene localization to 5q31. Am J Hum Genet 1998, 63:1732-1742.
16. Fischer D., Herasse M., Bitoun M., Barragán-Campos H.M., Chiras J., et al. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy. Brain 2006, 129:1463-1469.
17. Georgesco M., Salerno A. Spontaneous electromyographic activity. Practical importance. Neurophysiol Clin 2000, 30:289-305.
18. Gilbert J.R., Stajich J.M., Wall S., Carter S.C., Qiu H., Vance J.M., et al. Evidence for heterogeneity in facioscapulohumeral muscular dystrophy (FSHD). Am J Hum Genet 1993, 53:401-408.
19. Hanisch F., Müller T., Dietz A., Bitoun M., Kress W., Weis J., et al. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations. J Neurol 2011, 258:1085-1090.
20. Hanisch F., Kraya T., Kornhuber M., Zierz S. The diagnostic impact of myotonic discharges in myofibrillar myopathies. Muscle Nerve 2013, 47:845-848.
21. Hermanová M., Zapletalová E., Sedlácková J., Chrobáková T., Letocha O., Kroupová I., et al. Analysis of histopathologic and molecular pathologic findings in Czech LGMD2A patients. Muscle Nerve 2006, 33:424-432.
22. Hobson-Webb L.D., Dearmey S., Kishnani P.S. The clinical and electrodiagnostic characteristics of Pompe's disease with post-enzyme replacement therapy findings. Clin Neurophysiol 2011, 122:2312-2317.
23. Ishpekova B., Milanov I., Christova L.G., Alexandrov A.S. Comparative analysis between Duchenne and Becker types muscular dystrophy. Electromyogr Clin Neurophysiol 1999, 39:315-318.
24. Khadilkar S.V., Singh R.K., Kulkarni K.S., Chitale A.R. A study of clinical and laboratory features of 14 Indian patients with dysferlinopathy. J Clin Neuromuscul Dis 2004, 6:1-8.
25. Kimura J. Electrodiagnosis in Diseases of Nerve and Muscle 2001, Oxford Univ Press, Oxford. 3rd Ed.
26. Krasnianski M., Neudecker S., Eger K., Schulte-Mattler W., Zierz S. Nervenarzt 2003, 74:151-158.
27. Krasnianski M., Neudecker S., Deschauer M., Zierz S. Nervenarzt 2004, 75:770-775.
28. Liguori R., Fuglsang-Frederiksen A., Nix W., Fawcett P.R., Andersen K. Electromyography in myopathy. Neurophysiol Clin 1997, 27:200-203.
29. Logigian E.L., Ciafaloni E., Quinn L.C., Dilek N., Pandya S., Moxley R.T., et al. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy. Muscle Nerve 2007, 35:479-485.
30. Lotz B.P., Engel A.G., Nishino H., Stevens J.C., Litchy W.J. Inclusion body myositis. Observations in 40 patients. Brain 1989, 112:727-747.
31. Machuca-Tzili L., Brook D., Hilton-Jones D. Clinical and molecular aspects of the myotonic dystrophies: a review. Muscle Nerve 2005, 32:1-18.
32. Melberg A., Kretz C., Kalimo H., Wallgren-Pettersson C., Toussaint A., Böhm J., et al. Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset. Neuromuscul Disord 2010, 20:53-56.
33. Milone M., Liewluck T., Winder T.L., Pianosi P.T. Amyloidosis and exercise intolerance in ANO5 muscular dystrophy. Neuromuscul Disord 2012, 22:13-15.
34. Mori-Yoshimura M., Okuma A., Oya Y., Fujimura-Kiyono C., Nakajima H., Matsuura K., et al. Clinicopathological features of centronuclear myopathy in Japanese populations harboring mutations in dynamin 2. Clin Neurol Neurosurg 2012, 114:678-683.
35. Müller-Felber W., Horvath R., Gempel K., Podskarbi T., Shin Y., Pongratz D., et al. Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients. Neuromuscul Disord 2007, 17:698-706.
36. Nakagawa M., Matsuzaki T., Higuchi I., Fukunaga H., Inui T., Nagamitsu S., et al. Facioscapulohumeral muscular dystrophy: clinical diversity and genetic abnormalities in Japanese patients. Intern Med 1997, 36:333-339.
37. Nalini A., Gayathri N. Dysferlinopathy: a clinical and histopathological study of 28 patients from India. Neurol India 2008, 56:379-385.
38. Park Y.E., Kim H.S., Lee C.H., Nam T.S., Choi Y.C., Kim D.S. Two common mutations (p.Gln832X and c.663+1G>C) account for about a third of the DYSF mutations in Korean patients with dysferlinopathy. Neuromuscul Disord 2012, 22:505-510.
39. Pathak P., Sharma M.C., Sarkar C., Jha P., Suri V., Mohd H., et al. Limb girdle muscular dystrophy type 2A in India: a study based on semi-quantitative protein analysis, with clinical and histopathological correlation. Neurol India 2010, 58:549-554.
40. Poppe M., Cree L., Bourke J., Eagle M., Anderson L.V., Birchall D., et al. The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 2003, 60:1246-1251.
41. Schessl J., Kress W., Schoser B. Novel ANO5 mutations causing hyper-CK-emia, limb girdle muscular weakness and Miyoshi type of muscular dystrophy. Muscle Nerve 2012, 45:740-742.
42. Susman R.D., Quijano-Roy S., Yang N., Webster R., Clarke N.F., Dowling J., et al. Expanding the clinical, pathological and MRI phenotype of DNM2-related centronuclear myopathy. Neuromuscul Disord 2010, 20:229-237.
43. Tamhankar P.M., Phadke S.R. Clinical profile and molecular diagnosis in patients of facioscapulohumeral dystrophy from Indian subcontinent. Neurol India 2010, 58:436-440.
44. Ueyama H., Kumamoto T., Horinouchi H., Fujimoto S., Aono H., Tsuda T. Clinical heterogeneity in dysferlinopathy. Intern Med 2002, 41:532-536.
45. Urtasun M., Sáenz A., Roudaut C., Poza J.J., Urtizberea J.A., Cobo A.M., et al. Limb-girdle muscular dystrophy in Guipúzcoa (Basque Country, Spain). Brain 1998, 121:1735-1747.
46. Young N.P., Daube J.R., Sorenson E.J., Milone M. Absent, unrecognized, and minimal myotonic discharges in myotonic dystrophy type 2. Muscle Nerve 2010, 41:758-762.